https://finance.yahoo.com/news/sunshine-biopharma-reports-full-ended-120000917.html
MONTREAL, April 05, 2023 (GLOBE NEWSWIRE) –
Sunshine Biopharma Inc. (NASDAQ: “SBFM”)
First report after buying Nora Pharma!
Increased sales from $228,426 in 2021 to $4,345,603 in 2022, largely due to inclusion of the 72 days of Nora Pharma operations, the time since the closing of the acquisition.
The price of SBFM is really undervalued mostly because it's not a known company yet.
Can anybody calculate the right price target with all the new data available? (There is no analyst consensus yet)
Thank you
Leave a Reply